上海医药: 上海医药集团股份有限公司第八届董事会第二十四次会议决议公告

Group 1 - The board meeting of Shanghai Pharmaceuticals was held on August 28, 2025, with all nine directors present, meeting the legal requirements for quorum [1] - The board approved a proposal that had previously been reviewed and approved by the audit committee and independent directors, with a unanimous vote of 9 in favor and 0 against [1][2] - The chairman of the board, Yang Qiuhua, presided over the meeting, which included attendance from supervisors and some senior management [1] Group 2 - Yang Qiuhua, a related director, abstained from voting on the proposal, while the other eight non-related directors voted in favor, resulting in a vote of 8 in favor and 0 against [2]